{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:54:56Z","timestamp":1775868896992,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.humpath.2015.10.007","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T16:28:45Z","timestamp":1446654525000},"page":"49-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["CXCR4 overexpression correlates with poor prognosis in myasthenia gravis\u2013associated thymoma"],"prefix":"10.1016","volume":"49","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dazhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2015.10.007_bb0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2015.10.007_bb0010","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/1097-0142(19871201)60:11<2727::AID-CNCR2820601125>3.0.CO;2-D","article-title":"Thymoma. A clinicopathologic review","volume":"60","author":"Lewis","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2015.10.007_bb0015","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1200\/JCO.1999.17.7.2280","article-title":"Thymoma: state of the art","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2015.10.007_bb0020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines\u2014chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2015.10.007_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2015.10.007_bb0030","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine patterns in patients with cancer: a systematic review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2015.10.007_bb0035","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2015.10.007_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2407-14-49","article-title":"Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2015.10.007_bb0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.imbio.2012.05.006","article-title":"SDF-1\/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients","volume":"218","author":"Weiss","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.humpath.2015.10.007_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.humpath.2015.10.007_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.humpath.2015.10.007_bb0060","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2015.10.007_bb0065","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.athoracsur.2003.10.001","article-title":"Thymic tumors","volume":"77","author":"Detterbeck","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.humpath.2015.10.007_bb0070","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.humpath.2015.10.007_bb0075","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.athoracsur.2005.11.067","article-title":"Clinical value of the WHO classification system of thymoma","volume":"81","author":"Detterbeck","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.humpath.2015.10.007_bb0080","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3892\/ol.2011.267","article-title":"Protein expression status of p53 and epidermal growth factor receptor in thymoma","volume":"2","author":"Cui","year":"2011","journal-title":"Oncol Lett"},{"key":"10.1016\/j.humpath.2015.10.007_bb0085","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1158\/1078-0432.CCR-05-0070","article-title":"Analysis of cell cycle regulator proteins in encapsulated thymomas","volume":"11","author":"Baldi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2015.10.007_bb0090","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.18632\/oncotarget.3217","article-title":"CXCR4 over-expression and survival in cancer: a system review and meta-analysis","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2015.10.007_bb0095","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2015.10.007_bb0100","doi-asserted-by":"crossref","first-page":"e71864","DOI":"10.1371\/journal.pone.0071864","article-title":"Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2015.10.007_bb0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-008-9921-8","article-title":"Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)","volume":"113","author":"Holm","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2015.10.007_bb0110","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.humpath.2011.08.002","article-title":"Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary","volume":"43","author":"Sekiya","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2015.10.007_bb0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.juro.2013.08.052","article-title":"Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma","volume":"191","author":"Chen","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2015.10.007_bb0120","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1158\/1078-0432.CCR-04-1470","article-title":"Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma","volume":"11","author":"Katayama","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2015.10.007_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/thno.5376","article-title":"Small molecule inhibitors of CXCR4","volume":"3","author":"Debnath","year":"2013","journal-title":"Theranostics"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715004360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715004360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T07:47:15Z","timestamp":1567324035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817715004360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":25,"alternative-id":["S0046817715004360"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2015.10.007","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCR4 overexpression correlates with poor prognosis in myasthenia gravis\u2013associated thymoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2015.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}